Achieve Life Sciences (ACHV) has just received a rare Commissioner's National Priority Voucher from the FDA for its cytisinicline therapy targeting nicotine dependence in e-vaping. This move could ...

AJ Bell was able to grow its EPS at 33% per year over three years, sending the share price higher. The average annual share price increase of 21% is actually lower than the EPS growth. So it seems ...